Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAHON TECH (SHENZHEN) CO., LTD. Governance Information 2025

Oct 13, 2025

50661_rns_2025-10-13_b736da46-9f53-4ef2-9bb1-3ee3ec50de9a.pdf

Governance Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

DAHON

DAHON TECH (SHENZHEN) CO., LTD.

大行科工(深圳)股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 2543)

AMENDMENTS TO THE ARTICLES OF ASSOCIATION

This announcement is made pursuant to Rule 13.51(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

Reference is made to the announcement of DAHON TECH (SHENZHEN) CO., LTD. (the "Company") dated October 5, 2025 (the "Announcement") in relation to, among others, the partial exercise of the over-allotment option in respect of an aggregate of 1,121,000 H Shares. Unless the context otherwise requires, terms used herein shall have the same meanings as those defined in the Announcement.

Upon completion of partial exercise of the Over-allotment Option, the registered capital and total number of the shares of the Company were changed to RMB32,788,841 and 32,788,841 Shares, respectively. To reflect such changes in the registered capital and share capital structure of the Company, corresponding amendments were made to the articles of association of the Company (the "Articles of Association").

In accordance with the resolutions passed at the general meeting held on January 10, 2025, the general meeting of the Company has authorized the board of directors of the Company (the "Board") and persons authorized by the Board to make corresponding adjustments and amendments to the Articles of Association in respect of the changes in registered capital and shareholding structure of the Company. The amended Articles of Association are effective from October 13, 2025.

  • 1 -

Particulars of the amendments to the Articles of Association are as follows:

Original articles Amended articles
Article 2 The Company is a joint stock limited company established through the overall conversion of Shenzhen Meidahon Technology Co., Ltd. in accordance with the Company Law and other relevant laws, administrative regulations, departmental rules, normative documents and relevant provisions of the relevant regulatory authorities of the People's Republic of China (hereinafter known as “China” or “PRC”, for the purpose of the Articles of Association, excluding the Hong Kong Special Administrative Region (hereinafter known as “Hong Kong”), the Macau Special Administrative Region (hereinafter known as “Macau”) and Taiwan). Article 2 The Company is a joint stock limited company established through the overall conversion of Shenzhen Meidahon Technology Co., Ltd. in accordance with the Company Law and other relevant laws, administrative regulations, departmental rules, normative documents and relevant provisions of the relevant regulatory authorities of the People's Republic of China (hereinafter known as “China” or “PRC”, for the purpose of the Articles of Association, excluding the Hong Kong Special Administrative Region (hereinafter known as “Hong Kong”), the Macau Special Administrative Region (hereinafter known as “Macau”) and Taiwan).
The Company was registered with the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”) on [●] for the initial offering of [●] overseas listed shares (hereinafter referred to as the “H Shares”). The H Shares were listed on the Stock Exchange of Hong Kong Limited (hereinafter referred to as the “HKEX”) on [●]. The Company was registered with the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”) on [●] 14 July 2025 for the initial offering of [●] 7.92 million overseas listed shares (hereinafter referred to as the “H Shares”). The H Shares, which were listed on the Stock Exchange of Hong Kong Limited (hereinafter referred to as the “HKEX”) on [●] 9 September 2025. The Over-allotment Shares of 1.121 million H shares were listed on the HKEX on 9 October 2025.
  • 2 -

Original articles Amended articles
Article 5 As of the date before the initial public offering of H Shares, the registered capital of the Company is RMB23.3689 million. Upon completion of the initial public offering of H Shares, the registered capital of the Company will be RMB31.2889 million if the over-allotment option is not exercised, or RMB32.4689 million if the over-allotment option is exercised in full.

Upon completion of the initial public offering of H Shares, the share capital of the Company will consist of 31.2889 million ordinary shares, including 7.92 million H Shares (accounting for approximately 25% of the total number of the ordinary shares of the Company) and 23.3689 unlisted shares (accounting for approximately 75% of the total number of the ordinary shares of the Company) if the over-allotment option is not exercised; the share capital of the Company will consist of 32.4689 million ordinary shares, including 9.10 million H Shares (accounting for 28% of the total number of the ordinary shares of the Company) and 23.3689 million unlisted shares (accounting for approximately 72% of the total number of the ordinary shares of the Company) if the over-allotment option is exercised in full. | Article 5 As of the date before the initial public offering of H Shares, the registered capital of the Company is RMB23.3689 million. Upon completion of the initial public offering of H Shares, the registered capital of the Company will be RMB31.2889 million if the over-allotment option is not exercised, or RMB32.4689 million if the over-allotment option is exercised in full.

Upon completion of the initial public offering of H Shares, the share capital of the Company will consist of 31.2889 million ordinary shares, including 7.92 million H Shares (accounting for approximately 25% of the total number of the ordinary shares of the Company) and 23.3689 unlisted shares (accounting for approximately 75% of the total number of the ordinary shares of the Company) if the over-allotment option is not exercised; the share capital of the Company will consist of 32.4689 million ordinary shares, including 9.10 million H Shares (accounting for 28% of the total number of the ordinary shares of the Company) and 23.3689 million unlisted shares (accounting for approximately 72% of the total number of the ordinary shares of the Company) if the over-allotment option is exercised in full.

The registered capital of the Company is RMB32.788841 million, the share capital consists of 32.788841 million ordinary shares, including 9.041 million H Shares (accounting for approximately 27.57% of the total number of the ordinary shares of the Company) and 23.747841 unlisted shares (accounting for approximately 72.43% of the total number of the ordinary shares of the Company). |

  • 3 -

The industrial and commercial registration, filing and other matters in respect of the above amendments to the Articles of Association will be completed with the relevant government or regulatory authorities in the PRC in due course. The full text of the amended Articles of Association is available on the website of the Stock Exchange (www.hkexnews.hk) and the website of the Company (https://dahon.com).

By order of the Board

DAHON TECH (SHENZHEN) CO., LTD.

Dr. Hon Ta-Wei

Executive Director and Chairman of the Board

Shenzhen, PRC, October 13, 2025

As at the date of this announcement, the executive directors of the Company are Dr. Hon Ta-Wei, Ms. Li Guiyu, Ms. Liu Guocun and Ms. Lee Hsiu-Fen; and the independent non-executive directors of the Company are Dr. Lee Lai Sun Peter, Mr. Liu Xuequan and Mr. Zhao Gensheng.

– 4 –